New research establishes a link between Western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease.
The research has identified the western diet-induced microbial and metabolic contributors to liver disease, advancing understanding of the gut-liver axis, and, in turn, the development of dietary and microbial interventions for this global health threat.
“We’re just beginning to understand how food and gut microbiota interact to produce metabolites that contribute to the development of liver disease,” says co-principal investigator, Guangfu Li, associate professor in the department of surgery and department of molecular microbiology and immunology at the University of Missouri.
“However, the specific bacteria and metabolites, as well as the underlying mechanisms were not well understood until now. This research is unlocking the how and why.”
The gut and liver have a close anatomical and functional connection via the portal vein. Unhealthy diets change the gut microbiota, resulting in the production of pathogenic factors that affect the liver.
When the researchers fed mice foods high in fat and sugar, they discovered that the mice developed a gut bacteria called Blautia producta and a lipid that caused liver inflammation and fibrosis. That, in turn, caused the mice to develop non-alcoholic steatohepatitis or fatty liver disease, with similar features to the human disease.
“Fatty liver disease is a global health epidemic,” says Kevin Staveley-O’Carroll, professor in the surgery department, and one of the lead researchers. “Not only is it becoming the leading cause of liver cancer and cirrhosis, but many patients I see with other cancers have fatty liver disease and don’t even know it. Often, this makes it impossible for them to undergo potentially curative surgery for their other cancers.”
As part of this study, the researchers tested treating the mice with an antibiotic cocktail administered via drinking water. They found that the antibiotic treatment reduced liver inflammation and lipid accumulation, resulting in a reduction in fatty liver disease. These results suggest that antibiotic-induced changes in the gut microbiota can suppress inflammatory responses and liver fibrosis.
The study appears in Nature Communications. The authors declare that they have no conflicts of interest related to the study.
Source: University of Missouri
